India’s Deep-Tech Funding Gap: Anagha Rajesh’s Journey Highlights Startup Challenges

India’s startup ecosystem is facing renewed questions over its ability to support long-term scientific innovation following the reported experience of Bengaluru-based entrepreneur Anagha Rajesh. According to the account, Rajesh developed BioCompute, a laboratory focused on DNA-based data storage technology, which uses synthetic DNA to store large volumes of information in extremely small spaces. However, a lack of funding from domestic venture capitalists reportedly made it difficult to expand the venture, eventually leading her to sell the laboratory at a low price and move to the United States. The account further claims that investors in San Francisco showed interest in funding her work, highlighting the contrast between the funding environments in India and the US.

The episode has reignited debate over why Indian investors often favour consumer-facing businesses, such as ride-hailing and quick-commerce platforms, over research-intensive deep-tech ventures. Fields including biotechnology, genetics, semiconductors and advanced data storage can require five to seven years or longer to achieve commercial viability. Supporters of deep-tech innovation argue that these ventures need patient capital, research grants, intellectual property protection and investors willing to accept long development cycles and technical risks. The reported case has also prompted calls for stronger government support and dedicated long-term funding mechanisms. Experts say India’s ability to retain scientific talent and build globally competitive technology companies will depend on creating a funding ecosystem that values research and innovation alongside short-term commercial returns.